InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Meyers Michael L., Vice-Président Senior, Directeur Médical. Director active across 1 company, notably Syndax Pharmaceuticals Inc. Cumulatively, 4 reports have been published. History available since 30 December 2021. The latest transaction was filed on 31 January 2022 (J). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
1,714 shares@ US$12.390.0011% mcap14.7% of flowCommon StockSEC:0001562180-22-001078:0
1,714 shares@ US$12.390.0011% mcap29.5% of flowCommon StockSEC:0001562180-22-001078
5,900 shares@ US$8.770.0025% mcap70.5% of flowCommon StockSEC:0001562180-22-000035
5,900 shares@ US$8.770.0025% mcap35.3% of flowCommon StockSEC:0001562180-22-000035:0
4 of 4 declarations
About Meyers Michael L.
Michael L. Meyers is the Senior VP and Chief Medical Officer at Syndax Pharmaceuticals Inc. He is responsible for leading the company's medical and scientific initiatives. His expertise in biopharmaceuticals is essential for developing new treatments and innovation at Syndax.
